224. Purpura nephritis Clinical trials / Disease details

Clinical trials : 16 / Drugs : 43 - (DrugBank : 21) / Drug target genes : 15 - Drug target pathways : 58

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR2000037540	2020-09-30	2020-08-28	Effects and safety of MMF combined with short course steriods therapy in children Henoch-Schnlein purpura nephritis	Effects and safety of MMF combined with short course steriods therapy in children Henoch-Schnlein purpura nephritis	children Henoch-Schnlein purpura nephritis	experimental group:mycophenolate mofetil;control group:traditional course steriod;	Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine	NULL	Pending	2	14	Both	experimental group:30;control group:30;	N/A	China
2	NCT02532777 (ClinicalTrials.gov)	August 2015	20/8/2015	The Research of Standard Diagnosis and Treatment for HSPN in Children	The Research of Standard Diagnosis and Treatment for Henoch-Schonlein Purpura Nephritis in Children	Henoch-Schoenlein Purpura Nephritis	Drug: Prednisone;Drug: Cyclophosphamide (CTX);Drug: Mycophenolate mofetil (MMF);Drug: Leflunomide (LEF);Drug: Angiotensin -converting enzyme inhibitor(ACEI);Drug: Methylprednisolone	Nanjing Children's Hospital	NULL	Recruiting	2 Years	16 Years	All	100	Phase 2	China
3	NCT00301613 (ClinicalTrials.gov)	January 2003	10/3/2006	Mycophenolate Mofetil (MMF) Versus Intravenous CTX Pulses in the Treatment of Adult Severe HSPN	MMF Versus Intravenous CTX Pulses in the Treatment of Adult Severe Henoch-Schonlein Purpura Nephritis	Henoch-Schoenlein Purpura;Nephritis	Drug: Mycophenolate mofetil	Nanjing University School of Medicine	NULL	Completed	16 Years	50 Years	Both	60	N/A	China